TNF-α-driven m6A modification disrupts the immunoregulatory function of MSCs by regulating HDAC5-dependent super-enhancers
Weihao Zhang, Jiajie Lin, Yi Zhou, Changhua Wu, Qibo Li, Junhua Chen, Yipeng Zeng, Zipeng Xiao, Huiyong Shen, Yanfeng Wu, Zepeng Su, Wenhui Yu, Zhongyu Xie · 2025
Read TNF-α-driven m6A modification disrupts the immunoregulatory function of MSCs by regulating HDAC5-dependent super-enhancers by Weihao Zhang, Jiajie Lin, Yi Zhou, Changhua Wu, Qibo Li, Junhua Chen, Yipeng Zeng, Zipeng Xiao, Huiyong Shen, Yanfeng Wu, Zepeng Su, Wenhui Yu, Zhongyu Xie (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12728190.txt.
Description
Stem cell therapy for inflamed joints can backfire when the treatment cells land in an inflamed body, because the inflammation itself dulls their calming power. Weihao Zhang and co-authors traced that failure in 2025 to a chain of molecular switches inside mesenchymal stem cells. A signal called TNF-α tags one gene's message for destruction, lowering a protein that normally keeps a calming factor in check.
With the brake gone, super-enhancers switch the calming factor's gene too far the other way and the cells stop suppressing T cells properly. Stem cells engineered to keep the brake protein high worked better in arthritic mice. The authors propose the fix as a way to make cell therapy hold up in inflamed tissue.
Catalog record
| CREATOR | Weihao Zhang, Jiajie Lin, Yi Zhou, Changhua Wu, Qibo Li, Junhua Chen, Yipeng Zeng, Zipeng Xiao, Huiyong Shen, Yanfeng Wu, Zepeng Su, Wenhui Yu, Zhongyu Xie |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |